Almoosa Health Co.
4018XSAUSaudi Exchange·Healthcare
SAR 123.50
▼︎ 1.20%(-1.50)
Live
Data as of 13 May 2026
Open
SAR 125.00
High
SAR 125.00
Low
SAR 123.50
Volume
38.3K
52W High
SAR 212.00
52W Low
SAR 123.50
1W
-5.29%
1M
-11.28%
3M
-18.64%
6M
-29.15%
YTD
-29.15%
1Y
-25.78%
Mīzān Analysis
31/60
Mixed signals — review dimensions carefully
Low Liquidity
4018Sector
Market Cap
5.9B SAR
P/E
24.9
Revenue Growth
16.8%
Div Yield
0.98%
Rewards
No standout positive signals at current scores.
Risk Analysis
No significant risk flags at current scores.
Scores computed 13 May 2026
Fundamentals
Market Cap
P/E Ratio
P/B Ratio
EPS
EPS Growth
Revenue
Revenue Growth
Net Income
Profit Margin
Debt / Assets
Dividend Yield
Dividend Per Share
Shares Outstanding
Reporting Period: 2025-12-31Data as of Apr 24, 2026
Mizān Summary
News
Sector News10Industry & macro context
Trade ministers discuss final steps for GCC-UK FTA
Qatar Tribune· 1 day agoNeutralEconomy
UAE launches global plan to reach 42 million people, eradicate river blindness by 2030
Economy Middle East· 3 days agoNeutral
UAE Business: PureHealth surpasses $1.72bn in local procurement spend
Gulf Daily News· 7 days agoEconomy
Bahrain SWF Mumtalakat, SandboxAQ to boost Bahrain’s biotech sector
MSN· 12 days agoNeutralEconomy
Abu Dhabi’s PureHealth Q1 2026 revenue rises 10 percent to $2 billion on global expansion
Economy Middle East· 13 days agoNeutral
Omani delegation visits China to explore high tech pharmaceutical and medical ventures
Times of Oman· 16 days agoNeutralEconomy
Memo to enhance training, employment in pharmaceutical industry inked
وكالة الانباء الاردنية· 23 days agoNeutralEconomy
Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy
CNBC Business· 27 days agoNeutralMarket Movers
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
CNBC Business· 28 days agoPositiveMarket Movers
Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides
MarketWatch Top Stories· 28 days agoPositiveEconomy
Events
No upcoming corporate events